Myriad Genetics buy DerAlmanach100000
Start price
05.06.25
/
100%
€4.44
Target price
05.06.28
-
Performance (%)
8.56%
End price
06.08.25
€4.82
Summary
This prediction ended on 06.08.25 with a price of €4.82. With a performance of 8.56%, the BUY prediction by DerAlmanach100000 for Myriad Genetics closed with a slight gain. DerAlmanach100000 has a follow-up prediction for Myriad Genetics where he still thinks Myriad Genetics is a Buy. DerAlmanach100000 has 100% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | -10.294% | -10.294% |
| iShares Core DAX® | 2.554% | 0.562% |
| iShares Nasdaq 100 | 2.742% | -0.599% |
| iShares Nikkei 225® | 6.584% | 4.336% |
| iShares S&P 500 | 1.930% | -0.507% |
According to DerAlmanach100000 what are the pros and cons of Myriad Genetics for the foreseeable future?
Pros
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
Very Future proof/growth oriented business model
Market Leader or Top 3
Cons
Comments by DerAlmanach100000 for this prediction
In the thread Trading Myriad Genetics
Current prediction by DerAlmanach100000 for Myriad Genetics
Myriad Genetics
Start price
Target price
Perf. (%)
€6.30
23.11.25
23.11.25
-
23.11.28
23.11.28
-42.22%
09:46
09:46
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
Stopped prediction by DerAlmanach100000 for Myriad Genetics
Myriad Genetics
Start price
Target price
Perf. (%)
€4.34
03.06.25
03.06.25
-
03.07.25
03.07.25
8.29%
04.06.25
04.06.25
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
Myriad Genetics
Start price
Target price
Perf. (%)
€3.60
17.05.25
17.05.25
-
17.05.28
17.05.28
6.67%
28.05.25
28.05.25
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued